Top Markets
Coin of the day
Synairgen plc Synairgen plc

Synairgen plc

SNG
Hisse Senetlerindeki Sıralama #40400
Synairgen plc specializes in the research and development of pharmaceutical... Synairgen plc specializes in the research and development of pharmaceutical treatments for various respiratory conditions. Its product pipeline includes SNG001, an inhaled interferon beta currently being developed for COVID-19. The company is also advancing an inhaled form of interferon beta (IFN-ß) through Phase II clinical trials for the management of asthma triggered by common colds and influenza, as well as for the treatment or prevention of chronic obstructive pulmonary disease. Furthermore, Synairgen is developing a LOXL2 inhibitor intended for treating idiopathic pulmonary fibrosis (IPF). To support the development of this LOXL2 inhibitor, the company maintains a licensing and collaboration agreement with Pharmaxis Ltd. Synairgen plc was established in 2004 and is headquartered in Southampton, United Kingdom.
Hisse Fiyatı
$0.01292666
Son senkronizasyon: 2025-04-08
Piyasa Değeri
$157.54K
Değişim (1 gün)
6.84%
Değişim (1 yıl)
0.00%
Ülke
GB
Ticaret Synairgen plc (SNG)

Kategori

Synairgen plc (SNG) için kazanç
Jun 2024 itibarıyla kazanç TTM: $-4.64M
Synairgen plc şirketinin en son finansal raporlarına göre, mevcut kazancı $-4.64M'dir. 2022 yılında şirket $-24.31M kazanç elde etti, bu 2021 yılındaki $-78.22M kazanca göre önceki yıla göre artış. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Synairgen plc için kazanç geçmişi 2004 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
2026 (TTM) $-4.64M -62.26%
2023 $-12.29M -49.43%
2022 $-24.31M -68.92%
2021 $-78.22M 222.66%
2020 $-24.24M 281.43%
2019 $-6.36M 121,729.64%
2018 $-5.22K -336.99%
2017 $2.20K -100.05%
2016 $-4.20M 111,307.18%
2015 $-3.77K -315.15%
2014 $1.75K -100.05%
2013 $-3.75M -6.03%
2012 $-4.00M -32.03%
2011 $-5.88M 34.57%
2010 $-4.37M -6.90%
2009 $-4.69M -4.50%
2008 $-4.91M 29.79%
2007 $-3.78M 57.39%
2006 $-2.40M 119.97%
2005 $-1.09M 293.81%
2004 $-277.59K 0.00%
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
$5.27B -113,800.85%
US
$1.95B -42,146.41%
NL
- -
CH
- -
KR
$3.01B -64,888.45%
BE